2018 Æĸ¶½´Æ¼Äýº ÀÎ ÄÚ¸®¾Æ Pharmaceuticals in Korea
¾à¾÷½Å¹® ÆíÁýºÎ Àú | ¾à¾÷½Å¹®
¡ØÃ¥¼Ò°³
Pharmaceuticals in korea 2018Àº Çѱ¹Á¦¾à¹ÙÀÌ¿À»ê¾÷ ÇöȲ°ú Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ¸¦ ºñ·ÔÇÑ Á¦¾à°ü·Ã ´Üü¿¡ ¼Ò¼ÓµÈ »óÀå/ºñ»óÀå Á¦¾à±â¾÷µé¿¡ ´ëÇÑ ¸ðµç Á¤º¸¸¦ ÇÑ°÷¿¡ ¸ðÀº ¿µ¹®ÆÇ Ã¥ÀÚÀÌ´Ù. ÅõÀÚÁ¤º¸/±¸Á÷Á¤º¸/±â¾÷È«º¸¸¦ ÇÊ¿ä·Î ¸ðµç ºñÁî´Ï½º ´ÏÁî¿¡ ´ëÇØ ¿ø½ºÅ鼺ñ½º ÇÒ ¼ö ÀÖ´Â ÀÚ·á ¹× Á¤º¸¸¦ DBÈ ÇÏ°í ÀÖ´Ù.
¡Ø¸ñÂ÷
CHAPTER 1. PRESENT STATE OF PHARMACEUTICAL INDUSTRY
PART 1 : PHARMACEUTICAL INDUSTRY OVERVIEW
1) Pharmaceutical Industry Trend 10
A) The Fate of Korean Pharmaceutical Industry 10
B) Korean Pharmaceutical Market Size 11
C) Annual Pharmaceutical Manufacturing Performance 12
D) Annual ETC/OTC Drug Manufacturing Performance 13
E) Active Pharmaceutical Ingredients(API)/Finished Drug Manufacturing Performance 13
F) Manufacturing Performance By Therapeutic Category 14
G) Drug Manufacturing Performance By Top 30 Pharmaceutical Companies 14
H) Major ETC/OTC Drug Manufacturing Performance 17
I) Manufacturing Performance of Major Finished drugs 18
J) Manufacturing Performance of Active Pharmaceutical Ingredients(API) 19
K) Manufacturing Performance of Korean-Developed New Drugs 19
L) Manufacturing Performance of Incrementally Modified Drugs 21
M) Manufacturing Performance of Orphan Drugs 22
N) Bio Pharmaceuticals Lead Pharmaceutical Market Growth 23
2) Present State of Domestic...